Accueil / Tag Archives: Genetics

Tag Archives: Genetics

Global In situ Hybridization Market Forecast, 2019-2025 – FISH Displays the Potential to Grow at Over 5.9% – ResearchAndMarkets.com

Thursday, August 15th 2019 at 2:27pm UTC DUBLIN–(BUSINESS WIRE)– The « In situ Hybridization – Market Analysis, Trends, and Forecasts » report has been added to ResearchAndMarkets.com’s offering. In situ Hybridization market worldwide is projected to grow by US$282.5 Thousand, guided by a compounded growth of 5.6%. Staying on top of trends …

Plus »

Accellix Announces the Appointment of Charles Piazza to its Board of Directors

Wednesday, August 14th 2019 at 12:00pm UTC SAN JOSE, Calif.–(BUSINESS WIRE)– Accellix Inc. announces the appointment of a new Board Member, Mr. Charles Piazza. Charles (Chuck) Piazza, Accellix’s newest board member, has over 35 years of global experience within the life science industry serving the pharmaceutical, biotechnology and medical research …

Plus »

FDA Approves Genentech’s Rozlytrek (entrectinib) for People With ROS1-Positive, Metastatic Non-Small Cell Lung Cancer and NTRK Gene Fusion-Positive Solid Tumors

Thursday, August 15th 2019 at 8:10pm UTC – First FDA-approved treatment designed to target both ROS1 and NTRK that also shows response in cancer that has spread to the brain – – Genentech’s first FDA-approved tumor-agnostic medicine – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Genentech, a member of the Roche Group …

Plus »

City of Hope Now Enrolling Patients for First-in-Human T Cell Trial for HPV-Associated Cancers

Thursday, August 15th 2019 at 4:00pm UTC On the West Coast, City of Hope is the first institution to open the Kite-sponsored trial DUARTE, Calif.–(BUSINESS WIRE)– The first-in-human, phase 1 T cell trial for patients who have human papillomavirus (HPV)-associated cancers that have relapsed, or are resistant to treatment, is …

Plus »

GeneCentric Therapeutics Acquires Select ImmunoGenomics

Thursday, August 15th 2019 at 4:16pm UTC Combined company uniquely suited to drive precision oncology forward with RNA technologies to identify oncology drug responder populations DURHAM, N.C.–(BUSINESS WIRE)– GeneCentric Therapeutics, Inc. today announced that it has acquired Select ImmunoGenomics, LLC, a Chapel Hill, NC-based provider of advanced immunogenomic, data analysis …

Plus »

CTD Announces New Data Presented at Annual Gathering of Patients and Families Tackling Niemann-Pick Disease Type C

Thursday, August 15th 2019 at 12:00pm UTC CTD presentation to take place at the National Niemann-Pick Disease Foundation Conference August 16, 2019 ALACHUA, Fla.–(BUSINESS WIRE)– CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, today posted …

Plus »

Alnylam to Report New Clinical Results for Givosiran at the 2019 International Congress on Porphyrins and Porphyrias

Wednesday, August 14th 2019 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the Company and its collaborators will present at the 2019 International Congress on Porphyrins and Porphyria (ICPP), being held September 8-11, 2019 in Milan, Italy. Presentations will …

Plus »

Genomind Partners with NeuroFlow, Transforming Model of Care for Mental Health Patients

Monday, August 19th 2019 at 12:05pm UTC – Unique collaborative service combines innovative digital health platform and genetic testing to improve patient wellness and lower costs across the continuum of care for conditions including depression, anxiety, PTSD, and substance abuse – Software applications empower patient engagement and integrate synergistically with …

Plus »

AVROBIO Appoints Georgette Verdin as Chief Human Resources Officer

Friday, August 16th 2019 at 12:30pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– AVROBIO, Inc. (NASDAQ: AVRO) (“AVROBIO” or the “Company”), a Phase 2 clinical-stage gene therapy company, today announced the appointment of Georgette Verdin as Chief Human Resources Officer (CHRO). Ms. Verdin will be responsible for all aspects of human resources, including …

Plus »

Dyne Therapeutics Expands Board of Directors with Appointment of Lawrence Klein

Monday, August 19th 2019 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced the appointment of Lawrence Klein, Ph.D., to its Board of Directors. “Dyne’s FORCE therapeutic platform achieves a unique combination of tissue-specific delivery, high potency …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.